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Introduction 
Salmonella typhimurium (ST) is a primary cause of enteritis and subclinical 
production losses in growing or finishing swine. Due to the zoonotic potential, 
intervention programs for ST have been established attempting to reduce carcass 
contamination. The objective of this study was to evaluate Salmonella fecal shedding of 
pigs vaccinated with a commercial, avirulent live culture (ALC) Salmonella 
Choleraesuis-Typhimurium vaccine when challenged with virulent ST. 
 
Materials and methods 
Eight litters of two-week-old pigs were blocked by litter and 3 pigs/litter assigned 
to treatment groups; ALC vaccine group (n=24) and a placebo group (n=24). Both 
treatments were administered through the drinking water. Pigs were housed by 
treatment during the vaccination phase to avoid unintentional exposure of ALC vaccine 
to the placebo group and were re-penned individually with treatments comingled in the 
same room for the challenge phase. Four weeks after treatment, all pigs were challenged 
intranasally with 2mL of virulent ST (4x108 CFU/dose). Fecal samples were collected 
daily for 14 days post-challenge (DPC) then three times weekly until 84DPC. Fecal 
samples were tested via modified enrichment culture (lower detection limit 
~4000CFU/gram). 
 
Results 
During the 12-week challenge phase, the mean number of positive samples/pig 
was 26.2 (placebo) and 15.9 (vaccine) which was a significant improvement. All 
placebo pigs were positive from 3DPC to 6DPC, and ≥78.3% of placebo pigs continued 
to shed until 31DPC; then at least 47.8% of placebo pigs shed from 33DPC to 49DPC. 
For Vaccine pigs, 82.6% were positive the day after challenge which steadily declined 
to ≤13.0% from 47DPC through the end of the study. 
  
Discussion 
The vaccine group had significantly reduced shedding within two to six weeks 
post-challenge while several pigs in the placebo group continually shed through the 
challenge phase. Preliminary data suggests that the use of an ALC Salmonella 
Choleraesuis-Typhimurium vaccine clinically reduces fecal shedding in pigs post-
challenge. 
